Home LiteratureArticle Details
PMID: 1510412 Published · ppublish English Journal Article Review

In vivo antibiotic synergism: contribution of animal models.

Antimicrobial agents and chemotherapy ·Vol. 36 ·No. 5 ·1992-05-00 ·Pages 907-12

Fantin B, Carbon C

Abstract

暂无摘要

MeSH Terms
Animals Anti-Bacterial Agents Bacterial Infections/drug therapy Disease Models, Animal Drug Synergism Drug Therapy, Combination/therapeutic use
Chemicals
Anti-Bacterial Agents
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Fantin B
Service de Médecine Interne, Hôpital Bichat, Paris, France.
Carbon C
References (56)
56 references, click to expand
  1. Synergism of ampicillin and gentamicin against obstructive pyelonephritis due to Escherichia coli in rats.
    J Infect Dis. 1979 Feb;139(2):133-40 PMID: 374640
  2. Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis.
    Antimicrob Agents Chemother. 1987 Nov;31(11):1803-8 PMID: 3124739
  3. Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.
    Antimicrob Agents Chemother. 1976 Oct;10(4):646-51 PMID: 825035
  4. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    J Lab Clin Med. 1976 Jul;88(1):118-24 PMID: 1047088
  5. Antimicrobial therapy of experimental intraabdominal sepsis.
    J Infect Dis. 1975 Sep;132(3):282-6 PMID: 1159331
  6. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.
    Antimicrob Agents Chemother. 1991 Aug;35(8):1570-5 PMID: 1834013
  7. Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium.
    J Infect Dis. 1991 Nov;164(5):888-93 PMID: 1940467
  8. Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes.
    J Infect Dis. 1979 Sep;140(3):287-94 PMID: 115932
  9. Synergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo.
    Antimicrob Agents Chemother. 1977 Jun;11(6):956-64 PMID: 406837
  10. Therapy of neutropenic rats infected with Pseudomonas aeruginosa.
    J Infect Dis. 1976 May;133(5):538-47 PMID: 816976
  11. Experimental endocarditis due to Pseudomonas aeruginosa. II. Therapy with carbenicillin and gentamicin.
    J Infect Dis. 1977 Sep;136(3):327-35 PMID: 903671
  12. Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin.
    J Infect Dis. 1975 Nov;132(5):493-9 PMID: 1185015
  13. Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli.
    J Antimicrob Chemother. 1991 Jun;27(6):829-36 PMID: 1938689
  14. Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus.
    J Infect Dis. 1991 Mar;163(3):514-23 PMID: 1995724
  15. Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis.
    Antimicrob Agents Chemother. 1990 Dec;34(12):2387-91 PMID: 2128443
  16. Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo.
    Antimicrob Agents Chemother. 1989 May;33(5):608-11 PMID: 2502064
  17. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model.
    J Infect Dis. 1988 Oct;158(4):831-47 PMID: 3139779
  18. Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 1988 Jun;32(6):919-21 PMID: 3166360
  19. Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia.
    J Infect Dis. 1988 Jul;158(1):7-12 PMID: 3392422
  20. Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.
    Am J Med. 1987 Apr 27;82(4A):73-5 PMID: 3578332
  21. Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin.
    Antimicrob Agents Chemother. 1986 Nov;30(5):725-8 PMID: 3800348
  22. Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals.
    J Infect Dis. 1985 Jun;151(6):1028-33 PMID: 3846608
  23. Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1985 Dec;28(6):781-5 PMID: 3909954
  24. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
    J Infect Dis. 1985 Jan;151(1):157-65 PMID: 3965588
  25. Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis.
    J Infect Dis. 1974 May;129(5):572-6 PMID: 4823583
  26. Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus.
    J Infect Dis. 1981 Sep;144(3):237-43 PMID: 6268715
  27. Treatment of experimental ascending Escherichia coli pyelonephritis with ceftriaxone alone and in combination with gentamicin.
    Chemotherapy. 1982;28(5):410-6 PMID: 6291870
  28. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    J Infect Dis. 1984 Jun;149(6):980-5 PMID: 6429255
  29. Aztreonam, cefoperazone, and gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis in rabbits.
    Antimicrob Agents Chemother. 1983 Sep;24(3):321-4 PMID: 6685454
  30. Mezlocillin and ticarcillin alone and combined with gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis.
    Antimicrob Agents Chemother. 1984 Jun;25(6):683-6 PMID: 6742813
  31. Experimental osteomyelitis caused by Pseudomonas aeruginosa.
    J Infect Dis. 1980 Jan;141(1):71-5 PMID: 6767790
  32. Minimal concentrations of aminoglycoside that can synergize with penicillin in enterococcal endocarditis.
    Antimicrob Agents Chemother. 1981 Sep;20(3):405-9 PMID: 6795989
  33. Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis.
    Antimicrob Agents Chemother. 1982 Dec;22(6):972-5 PMID: 6818902
  34. Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin.
    J Infect Dis. 1983 Feb;147(2):352-7 PMID: 6827150
  35. Therapeutic efficacy of 29 antimicrobial regimens in experimental intraabdominal sepsis.
    Rev Infect Dis. 1981 May-Jun;3(3):535-42 PMID: 7025151
  36. Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditis.
    Antimicrob Agents Chemother. 1980 Dec;18(6):944-7 PMID: 7235680
  37. High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections.
    Ann Intern Med. 1989 Apr 1;110(7):515-20 PMID: 2923386
  38. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
    Eur J Clin Microbiol. 1986 Feb;5(1):23-8 PMID: 2938945
  39. Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
    J Antimicrob Chemother. 1986 Mar;17 Suppl A:11-8 PMID: 3086276
  40. Comparison of antibiotic regimens for treatment of experimental pneumonia due to Pseudomonas.
    J Infect Dis. 1979 Dec;140(6):881-9 PMID: 120384
  41. Penicillin-netilmicin synergism against Streptococcus faecalis.
    Antimicrob Agents Chemother. 1978 Mar;13(3):430-4 PMID: 122522
  42. Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase.
    Antimicrob Agents Chemother. 1990 Nov;34(11):2070-4 PMID: 2073099
  43. Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 1990 Dec;34(12):2312-7 PMID: 2128441
  44. Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.
    Antimicrob Agents Chemother. 1990 Apr;34(4):581-6 PMID: 2188586
  45. Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis.
    Antimicrob Agents Chemother. 1989 May;33(5):767-70 PMID: 2665645
  46. Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis.
    Antimicrob Agents Chemother. 1989 Aug;33(8):1184-7 PMID: 2802547
  47. Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains.
    Antimicrob Agents Chemother. 1985 Nov;28(5):663-6 PMID: 2936301
  48. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    J Infect Dis. 1986 Jul;154(1):69-75 PMID: 2940303
  49. Immunocompromised animal models for the study of antibiotic combinations.
    Am J Med. 1986 May 30;80(5C):45-52 PMID: 3087166
  50. Combination therapy: a way to limit emergence of resistance?
    Am J Med. 1986 Jun 30;80(6B):138-42 PMID: 3088999
  51. Challenging conventional aminoglycoside dosing regimens. The value of experimental models.
    Am J Med. 1986 Jun 30;80(6B):179-81 PMID: 3089001
  52. Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
    J Antimicrob Chemother. 1986 Jul;18(1):51-63 PMID: 3093445
  53. beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis.
    J Infect Dis. 1987 Jun;155(6):1226-32 PMID: 3106510
  54. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Am J Med. 1987 Apr 27;82(4A):44-54 PMID: 3107380
  55. In vivo postantibiotic effect in a thigh infection in neutropenic mice.
    J Infect Dis. 1988 Feb;157(2):287-98 PMID: 3121761
  56. Experimental osteomyelitis. V. Therapeutic trials with oxacillin and sisomicin alone and in combination.
    J Infect Dis. 1978 Feb;137(2):155-60 PMID: 627735
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
DOI
10.1128/AAC.36.5.907
Published
1992-05-00
Pages
907-12
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC188745
Subset
IM
External Links
PubMed source DOI: 10.1128/AAC.36.5.907 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2